Home / Poster / The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example

ポスター

The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example

サターラ、2024年の研究成果を発表 ―100本超の論文を公開

プレスリリース

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

お知らせ

Automated Writing Without the Compromise

製品紹介資料

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

ポスター

Powered by Translations.com GlobalLink Web Software

The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example

The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example

サターラ、2024年の研究成果を発表 ―100本超の論文を公開

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

Automated Writing Without the Compromise

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

メルマガ登録

クイックアクセス

ソリューション

お問合せ